{"url_path":"/sec/juns/8-k/2026-06-22/item-5-02","section_key":"item-5-02","section_title":"Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-22","source_url":"https://www.sec.gov/Archives/edgar/data/1679628/0001493152-26-029487-index.html","accession_number":"0001493152-26-029487","cik":"0001679628","ticker":"JUNS","issuer_name":"JUPITER NEUROSCIENCES, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1679628/0001493152-26-029487-index.html","primary_entity_key":"0001679628","primary_entity_name":"JUPITER NEUROSCIENCES, INC."},"word_count":125,"has_tables":true,"body_markdown":"**Item\n5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of\nCertain Officers.**\n\n** **\n\nOn\nJune 17, 2026, Allison W. Brady, a member of the Board of Directors (the “Board”) of Jupiter Neurosciences, Inc. (the “Company”),\ninformed the Company of her decision to resign from the Board, effective immediately. Ms. Brady also resigned from her positions as a\nmember of the Audit Committee and the Compensation Committee of the Board, effective as of the same date. Her decision to resign is not\nthe result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. Ms.\nBrady’s seat on the Board will remain vacant until the Company’s annual meeting on July 22, 2026."}